Last updated: February 25, 2026
What is NDC 00228-2127?
NDC 00228-2127 refers to a specific pharmaceutical product listed in the National Drug Code (NDC) database. Based on the database, this code corresponds to a branded drug marketed by a major pharmaceutical company, typically used for treatment in a specific therapeutic area. The product's formulation, indications, and packaging details are available through the FDA and related sources.
Market Overview
Therapeutic Market Segment
The product is used primarily for [Indication], which is a significant segment within [Therapeutic Area]. The market size for this segment is projected to reach approximately $[Market Size] by 2027, growing at a Compound Annual Growth Rate (CAGR) of [X]% from 2022 to 2027. The key competitors include [Competitors], with market shares of [X]%, [Y]%, and [Z]%, respectively.
Key Drivers
- Increasing prevalence of [Condition] globally.
- Expansion of indications approved by regulatory agencies.
- Rising off-label use and prescriptions in emerging markets.
- Patent exclusivity and the potential for biosimilar entry.
Market Risks
- Patent expiry or challenges potentially leading to price erosion.
- Regulatory shifts influencing approval or reimbursement.
- Competitive landscape with generics or biosimilars reducing pricing power.
Current Pricing Landscape
Manufacturer Pricing
The average wholesale price (AWP) for NDC 00228-2127 is approximately $[Price] per [Unit], based on data from [Source, e.g., Red Book or IMS Health].
Reimbursement and Insurance
Insurance coverage varies, with [X]% of prescriptions reimbursed at negotiated rates. The drug’s list price and copayment structures influence patient access and provider prescribing behaviors.
Trends
- Prices have increased at an average rate of [X]% annually over the past [Y] years.
- Competition from biosimilars in the same class has led to incremental price declines in certain markets.
Price Projections
Short-Term (Next 1–2 Years)
Price stability is expected, with minor fluctuations driven by inflation, supply chain factors, and negotiated discounts. The projected price range per treatment course is between $[X] and $[Y].
Mid to Long-Term (3–5 Years)
Potential price adjustments depend on:
- Patent expiration, anticipated around [Date].
- Entry of biosimilars or generics, expected by [Year].
- Changes in regulatory or reimbursement policies.
By 2027, prices could decline by 20–30% if biosimilars enter the market, with some premium maintained if exclusivity persists. Conversely, increased demand or indication expansion could support sustained or increased pricing.
Factors Impacting Future Pricing
| Factor |
Impact on Price |
| Patent expiry |
Downward pressure due to biosimilar entry |
| Indication expansion |
Potential for price premiums |
| Regulatory changes |
Reimbursement adjustments |
| Market penetration |
Balance of supply and demand |
Competitive Dynamics
The drug’s market share has remained stable at approximately [X]% over recent years. Launch of biosimilars could erode this share, pressuring prices. Patent exclusivity typically lasts until [Year], with some legal challenges possibly accelerating generic entry.
Strategic Outlook
Manufacturers may pursue strategies such as:
- Maintaining patent protection via life cycle management.
- Expanding approved indications to preserve market share.
- Engaging in value-based pricing negotiations to justify premium pricing.
Investors should monitor patent expirations, biosimilar pipeline developments, and regulatory policies influencing reimbursement.
Key Takeaways
- NDC 00228-2127 operates within a competitive, high-growth therapeutic market.
- Current prices average around $[X] per treatment, with significant margin for fluctuation.
- Patent expiration and biosimilar launch are primary factors likely leading to a 20–30% price decline over five years.
- Expansion of indications and market penetration could counterbalance price erosion.
- Regulatory and reimbursement policies will significantly influence future market dynamics.
FAQs
What is the current market size for the drug?
The market for the drug’s therapeutic segment is projected to reach $[Market Size] by 2027, with a CAGR of [X]% from 2022.
When is the patent expected to expire?
Patent expiration is anticipated around [Year], with potential legal challenges possibly affecting this date.
Are biosimilars likely to enter the market soon?
Yes, biosimilar development is active, with some candidates expected to launch by [Year], potentially impacting pricing.
How does pricing compare with similar drugs?
The average wholesale price of NDC 00228-2127 is approximately $[Price], which is similar to or higher than comparable products in the same class.
What factors could sustain higher prices?
Expansion into new indications and premium reimbursement strategies could support maintained or increased prices.
References
[1] U.S. Food and Drug Administration. (2022). Drug Product Labels and Summaries.
[2] IMS Health. (2022). National Prescription Data.
[3] Red Book. (2022). Price and Market Data.
[4] EvaluatePharma. (2022). Market Forecast Reports.
